Is vitamin B17 (amygdalin) safe or beneficial for medical use?

Vitamin B17 (Amygdalin) Is Not Safe and Should Not Be Used

Vitamin B17 (amygdalin/Laetrile) is a toxic substance that metabolizes into cyanide and has no proven medical benefit—it should be avoided entirely. Despite being marketed as an alternative cancer treatment and dietary supplement, amygdalin poses serious risks of life-threatening cyanide poisoning without demonstrable therapeutic efficacy 1, 2, 3.

Why Amygdalin Is Dangerous

Amygdalin is a cyanogenic glycoside that undergoes enzymatic hydrolysis in the body (via β-glucosidases in the intestine) to release hydrogen cyanide, benzaldehyde, and glucose 4, 5. The cyanide component is responsible for both its purported mechanism of action and its toxicity.

Documented Toxicity

• Life-threatening cyanide poisoning has been repeatedly documented in clinical practice, requiring emergency treatment with hydroxocobalamin 1, 6
• The 2023 AHA guidelines specifically address cyanide poisoning from amygdalin metabolism, recommending hydroxocobalamin as first-line treatment when cyanide toxicity occurs 1
• Between 2015-2022, the New South Wales Poisons Information Centre received 120 exposure calls, with 32% requiring hospital referral due to significant symptoms or exposure history 3
• Symptoms of cyanide toxicity include cardiovascular collapse, metabolic acidosis, elevated lactate, altered mental status, seizures, and death 1

Complete Lack of Clinical Efficacy

The definitive clinical trial evidence is unequivocal:

• A landmark 1982 clinical trial of 178 cancer patients treated with amygdalin plus "metabolic therapy" (diet, enzymes, vitamins) showed zero substantive benefit in terms of cure, tumor improvement, symptom relief, or life extension 2
• Patients in this trial were predominantly in good general condition, one-third had received no prior chemotherapy, yet none benefited
• The study concluded: "Amygdalin (Laetrile) is a toxic drug that is not effective as a cancer treatment" 2
• Two clinical studies from ~40 years ago confirmed no benefit in cancer patients, with proven toxicity 4

The Evidence Landscape

Preclinical Studies Are Misleading

While recent in vitro studies show effects on cell cycle, apoptosis, and various molecular pathways (COX-2, iNOS, E-cadherin, integrins), these do not translate to clinical benefit 4:

• In vivo animal studies demonstrate no or low treatment efficiency 4
• The gap between laboratory findings and human outcomes is vast and unbridgeable with current evidence
• Some animal studies (Drosophila) suggest protective effects against UV radiation, but these are irrelevant to human therapeutic use 7

Case Reports vs. Controlled Trials

Many anecdotal case reports describe anti-tumor effects, but these have never been confirmed in properly controlled clinical trials 4. This discrepancy represents classic confirmation bias and the natural history of cancer variability, not drug efficacy.

Clinical Management of Amygdalin Exposure

If a patient presents with suspected amygdalin/cyanide poisoning 1:

1. Administer hydroxocobalamin immediately (first-line antidote)
2. Sodium nitrite is an alternative when hydroxocobalamin is unavailable (but avoid if carbon monoxide co-poisoning is suspected)
3. Sodium thiosulfate can be added to enhance cyanide elimination
4. 100% oxygen should be administered
5. Monitor for cardiovascular collapse, metabolic acidosis, and elevated lactate

Key Monitoring Parameters

• Blood cyanide levels should be carefully monitored in any patient exposed to amygdalin 2
• Patients must be instructed about the danger of cyanide poisoning
• Watch for symptoms: altered mental status, seizures, cardiovascular instability, metabolic acidosis

Common Pitfalls

1. Marketing as "Vitamin B17": This is a misnomer—amygdalin is not a vitamin and has no recognized nutritional role in human physiology
2. Online availability: Despite FDA prohibition, amygdalin is readily available online as a "dietary supplement" or "alternative cancer therapy" 3
3. Patient desperation: Cancer patients seeking alternatives may be particularly vulnerable to unproven therapies
4. Delayed toxicity: Cyanide poisoning may not be immediately apparent, leading to dangerous accumulation

The Bottom Line

There is no safe or effective dose of amygdalin for any medical condition. The risk-benefit ratio is entirely unfavorable: proven toxicity with zero proven benefit. While some researchers suggest that controlled-release nanotechnology formulations might theoretically reduce toxicity 8, this remains entirely speculative and does not justify current use.

Patients should be strongly counseled against using vitamin B17/amygdalin products. If they have already been using these products, immediate discontinuation and evaluation for cyanide toxicity is warranted. The significant burden on poison control centers and emergency departments from amygdalin misuse represents preventable harm 3.